메뉴 건너뛰기




Volumn 18, Issue 8, 2003, Pages 591-593

Atypical antipsychotics and diabetic propensity: More questions than answers?

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; CLOZAPINE; GLUCOSE; INSULIN; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

EID: 0348230620     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/hup.533     Document Type: Editorial
Times cited : (3)

References (24)
  • 2
    • 0000649367 scopus 로고
    • The effect of chlorpromazine on glucose tolerance
    • Charatan FBE, Bartlett NG. 1955. The effect of chlorpromazine on glucose tolerance. J Mental Sci 191: 351-353.
    • (1955) J. Mental Sci. , vol.191 , pp. 351-353
    • Charatan, F.B.E.1    Bartlett, N.G.2
  • 3
    • 0025320188 scopus 로고
    • A study on the types of diabetes mellitus in first degree relatives of diabetic patients
    • Cheta D, Dumitrescu C, Georgescu M, et al. 1990. A study on the types of diabetes mellitus in first degree relatives of diabetic patients. Diabetes Metab 16: 11-15.
    • (1990) Diabetes Metab. , vol.16 , pp. 11-15
    • Cheta, D.1    Dumitrescu, C.2    Georgescu, M.3
  • 4
    • 24444457035 scopus 로고    scopus 로고
    • Investigation of the metabolic effects of antipsychotics in patients with schizophrenia
    • (Poster). 51st Annual Meeting of the Canadian Psychiatric Association, Quebec. Canadian Psychiatric Association: Quebec
    • Chue P, Welch R. 2001. Investigation of the metabolic effects of antipsychotics in patients with schizophrenia. (Poster). 51st Annual Meeting of the Canadian Psychiatric Association, Quebec. Canadian Psychiatric Association: Quebec.
    • (2001)
    • Chue, P.1    Welch, R.2
  • 5
    • 0033947811 scopus 로고    scopus 로고
    • Diabetic ketoacidosis associated with risperidone treatment?
    • Croarkin PE, Jacobs KM, Bain KB. 2000. Diabetic ketoacidosis associated with risperidone treatment? Psychosomatics 41: 369-370.
    • (2000) Psychosomatics , vol.41 , pp. 369-370
    • Croarkin, P.E.1    Jacobs, K.M.2    Bain, K.B.3
  • 6
    • 0033756432 scopus 로고    scopus 로고
    • Prevalence and correlates of diabetes in national schizophrenia samples
    • Dixon L, Weiden P, Delahunty J, et al. 2000. Prevalence and correlates of diabetes in national schizophrenia samples. Schizophrenia Bull 26: 903-912.
    • (2000) Schizophrenia Bull. , vol.26 , pp. 903-912
    • Dixon, L.1    Weiden, P.2    Delahunty, J.3
  • 7
    • 0036913786 scopus 로고    scopus 로고
    • Glucose intolerance with atypical antipsychotics
    • Hedenmalm K, Hagg S, Stahl M, et al. 2002. Glucose intolerance with atypical antipsychotics. Drug Safety 25: 1107-1116.
    • (2002) Drug Safety , vol.25 , pp. 1107-1116
    • Hedenmalm, K.1    Hagg, S.2    Stahl, M.3
  • 8
    • 0001205689 scopus 로고
    • Hyperglycaemia and glucosuria following chlorpromazine therapy
    • Hiles B. 1956. Hyperglycaemia and glucosuria following chlorpromazine therapy. J Am Med Assoc 162: 1651.
    • (1956) J. Am. Med. Assoc. , vol.162 , pp. 1651
    • Hiles, B.1
  • 9
    • 0347615169 scopus 로고    scopus 로고
    • Metabolic issues with atypical antipsychotics in primary care: Dispelling the myths
    • Kabinoff GS, Toalson P, Healey KM, et al. 2003. Metabolic issues with atypical antipsychotics in primary care: dispelling the myths. J Clin Psychiatry 5: 6-13.
    • (2003) J. Clin. Psychiatry , vol.5 , pp. 6-13
    • Kabinoff, G.S.1    Toalson, P.2    Healey, K.M.3
  • 10
    • 0000699617 scopus 로고
    • The blood sugar curve in mental disease 11. The schizophrenia (dementia praecox) group
    • Kasanin J. 1926. The blood sugar curve in mental disease 11. The schizophrenia (dementia praecox) group. Arch Neurol Psychiatry 16: 414-419.
    • (1926) Arch. Neurol. Psychiatry , vol.16 , pp. 414-419
    • Kasanin, J.1
  • 11
    • 0035990397 scopus 로고    scopus 로고
    • Olanzapine associated diabetes mellitus
    • Koller EA, Doraiswamy PM. 2002. Olanzapine associated diabetes mellitus. Pharmacotherapy 22: 841-852.
    • (2002) Pharmacotherapy , vol.22 , pp. 841-852
    • Koller, E.A.1    Doraiswamy, P.M.2
  • 12
    • 0037014941 scopus 로고    scopus 로고
    • Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: Population based nested control study
    • Koro CE, Fedder DO, L'Italien GJ, et al. 2002. Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested control study. Br Med J 332: 243-245.
    • (2002) Br. Med. J. , vol.332 , pp. 243-245
    • Koro, C.E.1    Fedder, D.O.2    L'Italien, G.J.3
  • 13
    • 0347615167 scopus 로고    scopus 로고
    • Prevalence of adult onset diabetes among outpatients receiving antipsychotic drugs
    • Lamberti J, Crilly J, Maharaj K, et al. 2003. Prevalence of adult onset diabetes among outpatients receiving antipsychotic drugs. Int Cong Schizophrenia Res 60: 360.
    • (2003) Int. Cong. Schizophrenia Res. , vol.60 , pp. 360
    • Lamberti, J.1    Crilly, J.2    Maharaj, K.3
  • 14
    • 0038220770 scopus 로고    scopus 로고
    • Patients on atypical antipsychotic drugs: Another high-risk group for type 2 diabetes
    • Lean MEJ, Pajonk F-G. 2003. Patients on atypical antipsychotic drugs: another high-risk group for type 2 diabetes. Diabetic Care 26: 1597-1605.
    • (2003) Diabetic Care , vol.26 , pp. 1597-1605
    • Lean, M.E.J.1    Pajonk, F.-G.2
  • 15
    • 0037315939 scopus 로고    scopus 로고
    • Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical and atypical antipsychotics
    • Lindenmayer JP, Czabar P, Volavka P. 2003. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical and atypical antipsychotics. Am J Psychiatry 190: 290-296.
    • (2003) Am. J. Psychiatry , vol.190 , pp. 290-296
    • Lindenmayer, J.P.1    Czabar, P.2    Volavka, P.3
  • 16
    • 84905057245 scopus 로고
    • Sugar tolerance in dementia praecox and other mental disorders
    • Lorenz WF. 1922. Sugar tolerance in dementia praecox and other mental disorders. Arch Neurol Psychiatry 8: 184-196.
    • (1922) Arch. Neurol. Psychiatry , vol.8 , pp. 184-196
    • Lorenz, W.F.1
  • 18
    • 0036252327 scopus 로고    scopus 로고
    • A retrospective comparison of weight, lipid and glucose changes between risperidone and olanzapine treated inpatients: Metabolic outcome after 1 year
    • Meyer JM. 2002. A retrospective comparison of weight, lipid and glucose changes between risperidone and olanzapine treated inpatients: metabolic outcome after 1 year. J Clin Psychiatry 63: 425-433.
    • (2002) J. Clin. Psychiatry , vol.63 , pp. 425-433
    • Meyer, J.M.1
  • 19
    • 0037223174 scopus 로고    scopus 로고
    • Prevalence of obesity, diabetes and obesity-related health risk factors, 2001
    • Mokdad AH, Ford ES, Bowman BA, et al. 2003. Prevalence of obesity, diabetes and obesity-related health risk factors, 2001. JAMA 289: 76-79.
    • (2003) JAMA , vol.289 , pp. 76-79
    • Mokdad, A.H.1    Ford, E.S.2    Bowman, B.A.3
  • 20
    • 0030062986 scopus 로고    scopus 로고
    • Diabetes mellitus in schizophrenic patients
    • Mukerjee S, Decina P, Bocola V, et al. 1996. Diabetes mellitus in schizophrenic patients. Comp Psychiatry 37: 68-73.
    • (1996) Comp. Psychiatry , vol.37 , pp. 68-73
    • Mukerjee, S.1    Decina, P.2    Bocola, V.3
  • 21
    • 0024565796 scopus 로고
    • Family history of type 2 diabetes in schizophrenic patients
    • (letter)
    • Mukherjee S, Schnur DB, Reddy R. 1989. Family history of type 2 diabetes in schizophrenic patients (letter). Lancet i: 495.
    • (1989) Lancet , vol.1 , pp. 495
    • Mukherjee, S.1    Schnur, D.B.2    Reddy, R.3
  • 22
    • 0037317444 scopus 로고    scopus 로고
    • Impaired fasting glucose tolerance in first-episode, drug-naïve patients with schizophrenia
    • Ryan MC, Collins P, Thakore JH. 2003. Impaired fasting glucose tolerance in first-episode, drug-naïve patients with schizophrenia. Am J Psychiatry 160: 284-289.
    • (2003) Am. J. Psychiatry , vol.160 , pp. 284-289
    • Ryan, M.C.1    Collins, P.2    Thakore, J.H.3
  • 23
    • 0043170918 scopus 로고    scopus 로고
    • Effect of acute psychotic stress in non-diabetic subjects on B cell function and insulin sensitivity
    • Shiloah E, Witz S, Abramovitch Y, et al. 2003. Effect of acute psychotic stress in non-diabetic subjects on B cell function and insulin sensitivity. Diabetes Care 26: 1462-1467.
    • (2003) Diabetes Care , vol.26 , pp. 1462-1467
    • Shiloah, E.1    Witz, S.2    Abramovitch, Y.3
  • 24
    • 24444458763 scopus 로고    scopus 로고
    • Risk factors for treatment emergent glucose abnormalities in patients with schizophrenia
    • Poster presentation, Collegium International Neuropsychopharmacologium, June 23-27. CINP: Montreal
    • Sowell MO, Mukhopadhyay N, Cavazzoni P. 2002. Risk factors for treatment emergent glucose abnormalities in patients with schizophrenia. Poster presentation, Collegium International Neuropsychopharmacologium, June 23-27. CINP: Montreal.
    • (2002)
    • Sowell, M.O.1    Mukhopadhyay, N.2    Cavazzoni, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.